Semcon has received an order from the Danish pharmaceuticals group Novo Nordisk
Semcon has received an order from the Danish pharmaceuticals group Novo Nordisk Semcon Industrial Design has been commissioned by the Danish group Novo Nordisk to project the redesign of an insulin factory in Kalundborg, Zealand, Denmark. The order includes process-technological design and programming and 15 consultants will be involved with the project initially. The present order is worth SEK 6 million and several similar commissions are already being discussed. The Danish Novo Nordisk group is active within two main areas: Enzymes and Health Care. Within Health Care insulin production is